CK Life Sciences Int'l., (Holdings) Inc.
CIK 1297567 · View on SEC EDGAR ↗
First SEC filing: Oct. 28, 2025 · Latest: Oct. 28, 2025
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 12, 2025 | DWTX | A | 284 | $7.01 | $1,991 | 284 Indirect | — | Acquired | -65.6% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 12, 2025 | DWTX | Series A-1 Preferred Stock | Common Stock (2,842,638) | — | — | 284 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).